Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix

Gynecologic Oncology

Volumn 129, Issue 3, 2013, Pages 513-516

  Costales, Anthony B ^a   Milbourne, Andrea M ^a   Rhodes, Helen E ^a   Munsell, Mark F ^b   Wallbillich, John J ^a   Brown, Jubilee ^a   Frumovitz, Michael ^a   Ramondetta, Lois M ^a   Schmeler, Kathleen M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cervical adenocarcinoma in situ; Cervical cancer; Cervical cone biopsy; Cervical dysplasia

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY DEVICE; CANCER ADJUVANT THERAPY; CLASSIFICATION ALGORITHM; COLD KNIFE CONE; CONSERVATIVE TREATMENT; ELECTROSURGERY; FEMALE; FOLLOW UP; GYNECOLOGIC SURGERY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LOOP ELECTROSURGICAL EXCISION PROCEDURE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; RECURRENCE RISK; SURGICAL RISK; UNITED STATES; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CARCINOMA IN SITU; COHORT STUDIES; CONIZATION; CRYOSURGERY; ELECTROSURGERY; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM, RESIDUAL; RISK FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84877581925     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.03.015     Document Type: Article

References (30)

1. T. Hepler, M.B. Dockerty, and L.M. Randall Primary adenocarcinoma of the cervix Am J Obstet Gynecol 63 1952 800 808
2. C.H. Shin, J.O. Schorge, K.R. Lee, and E.E. Sheets Conservative management of adenocarcinoma in situ of the cervix Gynecol Oncol 79 1 Oct 2000 6 10
3. M.M. Madeleine, J.R. Daling, and S.M. Schwartz Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix Cancer Epidemiol Biomarkers Prev 10 2001 171 177
4. T.R. Denehy, C.A. Gregori, and J.L. Breen Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix Obstet Gynecol 90 1997 1 6
5. A.W. Kennedy, and C.V. Biscotti Further study of the management of cervical adenocarcinoma in situ Gynecol Oncol 86 2002 361 364
6. E.S. Andersen, and K. Nielsen Adenocarcinoma in situ of the cervix: a prospective study of conization as definitive treatment Gynecol Oncol 86 2002 365 369
7. M.T. McHale, T.D. Le, R.A. Burger, M. Gu, J.L. Rutgers, and B.J. Monk Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix Obstet Gynecol 98 5 Pt 1 Nov 2001 726 731
8. R. Salani, I. Puri, and R.E. Bristow Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status Am J Obstet Gynecol 200 2009 182.e1 182.e5
9. P. Bryson, R. Stulberg, L. Sheperd, K. McLelland, and J. Jeffrey Is electrosurgical loop excision with negative margins sufficient treatment for cervical ACIS Gynecol Oncol 93 2004 465 468
10. J.K. Wolf, C. Levenback, A. Malpica, M. Morris, T. Burke, and M.F. Mitchell Adenocarcinoma in situ of the cervix: significance of cone biopsy margins Obstet Gynecol 88 1 Jul 1996 82 86
11. E.A. Poynor, R.R. Barakat, and W.J. Hoskins Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix Gynecol Oncol 57 1995 158 164
12. H.G. Muntz Can cervical adenocarcinoma in situ be safely managed by conization alone Gynecol Oncol 61 1996 301 303
13. S.L. Bull-Phelps, E.I. Garner, C.S. Walsh, P.A. Gehrig, D.S. Miller, and J.O. Schorge Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix Gynecol Oncol 107 2 Nov 2007 316 319
14. D.D. Im, L.R. Duska, and N.B. Rosenshein Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease Gynecol Oncol 59 2 Nov 1995 179 182
15. A.B. Costales, P.J. Eifel, and M.T. Deavers Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14 years following hysterectomy for adenocarcinoma in situ of the cervix Gynecol Oncol Rep 2 2012 97 99
16. T. Widrich, A.W. Kennedy, and T.M. Myers Adenocarcinoma in situ of the uterine cervix: management and outcome Gynecol Oncol 61 1997 304 308
17. C. Kietpeerakool, S. Khunamornpong, and J. Srisomboon Predictive value of negative cone margin status for risk of residual disease among women with cervical adenocarcinoma in situ Int J Gynecol Obstet 119 2012 266 269
18. T.C. Krivak, B. Retherford, S. Voskuil, G.S. Rose, and T. Alagoz Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ Gynecol Oncol 77 2 May 2000 334 335
19. M.P. Hopkins Adenocarcinoma in situ of the cervix - the margins must be clear Gynecol Oncol 79 2000 4 5
20. S. Costa, G. Negri, and M. Sideri Human Papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix Gynecol Oncol 106 2007 107 176
21. S. Costa, S. Venturoli, and G. Negri Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 cases Gynecol Oncol 124 2012 490 495
22. T.C. Wright, S.L. Massad, and C.J. Dunton 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ Am J Obstet Gynecol 197 2007 340 345
23. M. Kyrgiou Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis Lancet 367 9509 2006 489 498
24. S. Albrechtsen Pregnancy outcome in women before and after cervical conisation: population based cohort study BMJ 337 2008 a1343
25. M. Arbyn Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis BMJ 337 2008 a1284
26. B. Miller, J. Dunn, J. Dalrymple, and T.C. Krivak Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ Gynecol Oncol 99 2 Nov 2005 489 492
27. M.P. Hopkins, J.A. Roberts, and R.W. Schmidt Cervical adenocarcinoma in situ Obstet Gynecol 71 1988 842 844
28. W.P. Soutter, D. Haidopoulos, and R.J. Gornall Is conservative treatment for adenocarcinoma in situ of the cervix safe Br J Obstet Gynaecol 108 2001 1184 1189
29. D.M. Hwang, G.M. Lickrish, W. Chapman, and T.J. Colgan Long-term surveillance is required for all women treated for cervical adenocarcinoma in situ J Low Genit Tract Dis 8 2 2004 125 131
30. A.G. Ostor, A. Duncan, M. Quinn, and R. Rome Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases Gynecol Oncol 79 2 Nov 2000 207 210